XTSX
PINK
Market cap19mUSD
Jun 18, Last price
0.30CAD
1D
0.00%
1Q
-36.56%
Jan 2017
227.78%
Name
Perimeter Medical Imaging AI Inc
Chart & Performance
P/E
—
P/S
32.41
EPS
—
Div Yield, %
—
Shrs. gr., 5y
41.01%
Rev. gr., 5y
%
Revenues
846k
+109.70%
Net income
-13m
L-29.30%
CFO
-15m
L+0.18%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Perimeter Medical Imaging AI, Inc., established in 2013 and headquartered in Toronto, Canada, is a medical technology innovator. The company focuses on creating and marketing sophisticated imaging solutions that empower surgeons, radiologists, and pathologists to meticulously examine microscopic tissue details throughout clinical interventions. A cornerstone of their offerings is an advanced Optical Coherence Tomography (OCT) imaging system, providing clinicians with precise cross-sectional views of tissue up to a depth of 2 millimeters. This comprehensive system incorporates the S-series OCT, B-series OCT units, and a dedicated imaging console. Complementing this, Perimeter also provides ImgAssist, an artificial intelligence (AI) platform. This technology is engineered to streamline image review processes and, when integrated with their OCT system, serves as a powerful aid for physicians. It facilitates the real-time visualization and assessment of surgical margins, thereby enhancing patient outcomes and minimizing the necessity for subsequent operations. Furthermore, the company furnishes hospitals and specialized cancer treatment centers with its proprietary image library and consumable specimen containers.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||